Cancer Letters
Volume 224, Issue 2 , Pages 185-191 , 28 June 2005

Loss of heterozygosity at the BRCA1 locus in Tunisian women with sporadic breast cancer

Received 4 August 2004 ,Revised 30 October 2004 ,Accepted 2 November 2004.

References 

  1. Yang Q, Sakurai T, Mori I, Yoshimura G, Nakamura M, Nakamura Y, et al. Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer. 2001;92:54–60
  2. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer. 1993;54:594–606
  3. Weinberg RA. Tumor suppressor genes. Science. 1991;254:1138–1146
  4. Barnes DM. Expression and function of BRCA1 and BRCA2 in familial and sporadic breast cancer. Histopathology. 1999;34:170–174
  5. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71
  6. Wang Q, Zhang H, Fishel R, Greene MI. BRCA1 and cell signaling. Oncogene. 2000;19:6152–6158
  7. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature. 2000;408:429–432
  8. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994;266:120–122
  9. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 1993;52:678–701
  10. Sorlie T, Andersen TI, Bukholm I, Borresen-Dale AL. Mutation screening of BRCA1 using PTT and LOH analysis at 17q21 in breast carcinomas from familial and non-familial cases. Breast Cancer Res. Treat. 1998;48:259–264
  11. Yang Q, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, Umemura T, et al. BRCA1 in non-inherited breast carcinomas (review). Oncol. Rep. 2002;9:1329–1333
  12. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat. Genet. 1995;9:444–450
  13. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, et al. Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin. Cancer Res. 1999;6:1249–1261
  14. Osborne RJ, Hamshere MG. A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer. Cancer Res. 2000;60:3706–3712
  15. Miller BJ, Wang D, Krahe R, Wright FA. pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. Am. J. Hum. Genet. 2003;73:748–767
  16. Beckmann MW, Picard F, An HX, van Roeyen CR, Dominik SI, Mosny DS, et al. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br. J. Cancer. 1996;73:1220–1226
  17. Hanby AM, Kelsell DP, Potts HW, Gillett CE, Bishop DT, Spurr NK, et al. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer. Int. J. Cancer. 2000;88:204–208
  18. Rouba A, Kaisi N, Al-Chaty E, Badin R, Pals G, Young C, et al. Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer. Int. J. Mol. Med. 2000;6:565–569
  19. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas J, Wabinga H, et al. Breast cancer. In: in: Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications No. 153. Lyon, France: IARC Press; 2003;pp. 262–267
  20. Mourali N, Muenz LR, Tabbane F, Belhassen S, Bahi J, Levine PH. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer. 1980;46:2741–2746
  21. Hutter RV. At last-worldwide agreement on the staging of cancer. Arch. Surg. 1987;122:1235–1239
  22. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403–410
  23. Ausubel FM, Brent R, Moore DD, Seidman JC, Smith JA, Struhl K. Current Protocols in Molecular Biology. New York: Wiley; 1995;
  24. Pestonjamasp PH, Mittra I. Analysis of BRCA1 involvement in breast cancer in Indian women. J. Biosci. 2000;25:19–23
  25. Lo YL, Yu JC, Huang CS, Tseng SL, Chang TM, Chang KJ, et al. Allelic loss of the BRCA1 and BRCA2 genes and other regions on 17q and 13q in breast cancer among women from Taiwan (area of low incidence but early onset). Int. J. Cancer. 1998;79:580–587
  26. Silva JM, Gonzalez R, Provencio M, Dominguez G, Garcia JM, Gallego I, et al. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer. Breast Cancer Res. Treat. 1999;53:9–17
  27. Bocker T, Diermann J, Friedl W, Gebert J, Holinski-Feder E, Karner-Hanusch J, et al. Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res. 1997;57:4739–4743
  28. Shen CY, Yu JC, Lo YL, Kuo CH, Yue CT, Jou YS, et al. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res. 2000;60:3884–3892
  29. Niederacher D, Picard F, van Roeyen C, An HX, Bender HG, Beckmann MW. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer. 1997;18:181–192
  30. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990;250:1684–1689
  31. Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, et al. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer. 1998;79:334–432
  32. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, et al. Localization of human BRCA1 and its loss in high-grade non-inherited breast carcinomas. Nat. Genet. 1999;21:236–240
  33. Futreal PA, Soderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, et al. Detection of frequent allelic loss on proximal 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res. 1992;52:2624–2627
  34. Yamashita T, Iwase H, Yamashita I, Iwata H, Ito K, Toyama T, et al. Low frequency loss of heterozygosity in the BRCA1 region in Japanese sporadic breast cancer. Breast Cancer. 1996;3:167–172
  35. Maalej M, Frikha H, Ben Salem S, Daoud J, Bouaouina N, Ben Abdallah M, et al. Breast cancer in Tunisia: clinical and epidemiological study. Bull. Cancer. 1999;86:302–306
  36. Ben Ahmed S, Aloulou S, Bibi M, Landolsi A, Nouira M, Ben Fatma L, et al. Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients. Sante Publique. 2002;14:231–241
  37. Costa J, Webber BL, Levine PH, Muenz L, O'Conor GT, Tabbane F, et al. Histopathological features of rapidly progressing breast carcinoma in Tunisia: a study of 94 cases. Int. J. Cancer. 1982;30:35–37
  38. Jones BA, Kasl SV, Howe CL, Lachman M, Dubrow R, Curnen MM, et al. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer. 2004;101:1293–1301
  39. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J. Clin. 2003;53:342–355
  40. Santos SC, Cavalli LR, Cavalli IJ, Lima RS, Haddad BR, Ribeiro EM. Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil. J. Clin. Pathol. 2004;57:374–377

PII: S0304-3835(04)00866-3

doi: 10.1016/j.canlet.2004.11.001

Cancer Letters
Volume 224, Issue 2 , Pages 185-191 , 28 June 2005

Article Tools

* Image Usage & Resolution